PolarityTE, Inc. today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,” or “COVER DFUs.” COVER DFUs will enroll up to 100 subjects…

Þetta efni er eingöngu fyrir ÓKEYPIS ÁSKRIFT áskrifendur.
Skrá inn Taktu þátt núna

HVAÐ Á AÐ TAKA ÚR ÞESSARI GREIN:

today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,”.
Þetta efni er eingöngu fyrir ÓKEYPIS ÁSKRIFT áskrifendur.
COVER DFUs will enroll up to 100 subjects….